Want to join the conversation?
$CVS 2Q15 PR: Net revenues increased 7.4% to $37.2Bil vs. $34.6Bil in 2Q14. Net income was $1.27Bil vs. $1.25Bil in 2Q14. Gross profit was $6.4Bil vs. $6.3Bil in 2Q14. Operating profit increased 2.5% to $2.26Bil vs. $2.21Bil in 2Q14. Diluted EPS was $1.12 vs. $1.06 in 2Q14. Dividends declared per share were $0.350 vs. $0.275 in 2Q14.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.